Neostigmine Methylsulfate (West-Ward Pharmaceuticals Corp.)
Welcome to the PulseAid listing for the Neostigmine Methylsulfate drug offered from West-Ward Pharmaceuticals Corp.. This Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | West-Ward Pharmaceuticals Corp. |
| NON-PROPRIETARY NAME: | Neostigmine Methylsulfate |
| SUBSTANCE NAME: | NEOSTIGMINE METHYLSULFATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cholinesterase Inhibitor [EPC],Cholinesterase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2015-12-28 |
| END MARKETING DATE: | 0000-00-00 |
Neostigmine Methylsulfate HUMAN PRESCRIPTION DRUG Details:
| Item Description | Neostigmine Methylsulfate from West-Ward Pharmaceuticals Corp. |
| LABELER NAME: | West-Ward Pharmaceuticals Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1(mg/mL) |
| START MARKETING DATE: | 2015-12-28 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0641-6149_fe9a09f7-6c45-4f71-bbcb-297ed0dc5af4 |
| PRODUCT NDC: | 0641-6149 |
| APPLICATION NUMBER: | ANDA207042 |
Other NEOSTIGMINE METHYLSULFATE Pharmaceutical Manufacturers / Labelers:
